Catalyst Pharmaceuticals
CPRX
#4017
Rank
โ‚ฌ2.61 B
Marketcap
21,28ย โ‚ฌ
Share price
0.16%
Change (1 day)
5.86%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2025 (TTM): โ‚ฌ0.24 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.58 Billion. , an increase over its 2024 earnings that were of โ‚ฌ0.18 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.24 B31.1%
2024 โ‚ฌ0.18 B128.82%
2023 โ‚ฌ80.5 M-9.75%
2022 โ‚ฌ89.19 M98.83%
2021 โ‚ฌ44.86 M25.73%
2020 โ‚ฌ35.68 M25.38%
2019 โ‚ฌ28.45 M-198.25%
2018 -โ‚ฌ28.97 Million84.68%
2017 -โ‚ฌ15.69 Million1.88%
2016 -โ‚ฌ15.4 Million-10.68%
2015 -โ‚ฌ17.24 Million30.46%
2014 -โ‚ฌ13.22 Million27.6%
2013 -โ‚ฌ10.36 Million198.17%
2012 -โ‚ฌ3.48 Million-36.22%
2011 -โ‚ฌ5.45 Million59.52%
2010 -โ‚ฌ3.42 Million-44.68%
2009 -โ‚ฌ6.17 Million-31.45%
2008 -โ‚ฌ9 Million155.21%
2007 -โ‚ฌ3.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.57 B 11,734.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.68 B 3,494.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.21 B 2,886.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-188.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.24 Billion-195.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.41 B 70.18%๐Ÿ‡บ๐Ÿ‡ธ USA